Condition: Brain · Cancer · Sponsor: Attikon Hospital
The survival interval of patients with gliomas ranges between 12 to 15 months. Recent findings revealed that dietary interventions to reduce glucose and glycolytic pathways could have a therapeutic effect. Ketosis can be an effective therapy to extend the survival of patients with gliomas.
This description comes directly from the study's public registry record.
Arezina N. Kasti, RD · +306942917860 · kastiare@yahoo.gr
Evangelos K. Papadopoulos, MD · 6936251274 · neuroevan@yahoo.gr
Always discuss trial participation with your own doctor first.
| Arezina Kasti | Chaïdári, Athens, Greece | Recruiting |
| Attikon University General Hospital | Athens, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05564949